首页> Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer> Resectable Clinical N2 Non-Small Cell Lung Cancer; What Is the Optimal Treatment Strategy? An Update by the British Thoracic Society Lung Cancer Specialist Advisory Group.

Resectable Clinical N2 Non-Small Cell Lung Cancer; What Is the Optimal Treatment Strategy? An Update by the British Thoracic Society Lung Cancer Specialist Advisory Group.

导出原文传递

翻译打印收藏纠错

第一作者： Matthew,Evison

第一单位： Manchester Thoracic Oncology Centre, University Hospital of South Manchester, Manchester, United Kingdom. Electronic address: matthew.evison@uhsm.nhs.uk.

作者： Matthew,Evison ^[1] ; Amelia,Clive ^[2] ; Lianne,Castle ^[3] ; Helen,Powell ^[4] ; Rachel,Thomas ^[5] ; Robert,Buttery ^[6] ; Vidan,Masani ^[7] ; Susan,Harden ^[8] ; Doug,West ^[9] ; Ian,Woolhouse ^[10]

作者单位： Manchester Thoracic Oncology Centre, University Hospital of South Manchester, Manchester, United Kingdom. Electronic address: matthew.evison@uhsm.nhs.uk. ^[1] North Bristol Lung Centre, Southmead Hospital, North Bristol National Health Service Trust, Bristol, United Kingdom. ^[2] Department of Respiratory Medicine, Stoke Mandeville Hospital, Buckinghamshire, United Kingdom. ^[3] Frimley Park Hospital National Health Service Foundation Trust, Frimley, Surrey, United Kingdom. ^[4] Lung Cancer Clinical Nurse Specialist and Palliative Care Department, Guy's and St. Thomas' National Health Service Foundation Trust, London, United Kingdom. ^[5] Papworth Hospital National Health Service Foundation Trust, Cambridge, United Kingdom. ^[6] Royal United Hospitals Bath National Health Service Foundation Trust, Bath, United Kingdom. ^[7] Department of Clinical Oncology, Cambridge University Hospitals National Health Service Foundation Trust, United Kingdom. ^[8] Department of Thoracic Surgery, University Hospitals Bristol National Health Service Foundation Trust, Bristol, United Kingdom. ^[9] Department of Respiratory Medicine, University Hospitals Birmingham National Health Service Foundation Trust, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom. ^[10]

关键词 N2 NSCLC Non–small cell lung cancer Radiotherapy Thoracic surgery

医学主题词癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);英格兰(England);女(雌)性(Female);人类(Humans);肺肿瘤(Lung Neoplasms);男(雄)性(Male);治疗结果(Treatment Outcome)

DOI 10.1016/j.jtho.2017.05.023

PMID 28624466

发布时间 2018-10-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交